Drug Shortage Report for VENLAFAXINE XR
Report ID | 93859 |
Drug Identification Number | 02354713 |
Brand name | VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 37.5MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-09-23 |
Actual start date | 2019-09-27 |
Estimated end date | 2019-11-15 |
Actual end date | 2019-11-13 |
Shortage status | Resolved |
Updated date | 2019-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-11-14 | English | Compare |
v11 | 2019-11-13 | French | Compare |
v10 | 2019-11-13 | English | Compare |
v9 | 2019-09-28 | English | Compare |
v8 | 2019-09-27 | French | Compare |
v7 | 2019-09-27 | English | Compare |
v6 | 2019-09-27 | French | Compare |
v5 | 2019-09-27 | English | Compare |
v4 | 2019-09-24 | English | Compare |
v3 | 2019-09-13 | French | Compare |
v2 | 2019-09-13 | English | Compare |
v1 | 2019-09-13 | English | Compare |
Showing 1 to 12 of 12